| Amy Elizabeth Kayl, DO | |
|
27961 Us Highway 98 Ste 14, Daphne, AL 36526-4725 | |
| (251) 626-1175 | |
| (251) 625-1507 |
| Full Name | Amy Elizabeth Kayl |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 11 Years |
| Location | 27961 Us Highway 98 Ste 14, Daphne, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740623750 | NPI | - | NPPES |
| 78631 | Other | BLUE CROSS BLUE SHIELD OF ALABAMA. |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | DO1471 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Thomas Hospital | Fairhope, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Imc-eastern Shore Family Practice Llc | 7315218450 | 5 |
News Archive
"Food crises are jeopardizing efforts to achieve the Millennium Development Goal (MDG) of halving the proportion of people who suffer from hunger by 2015, United Nations (U.N.) food experts warned" on Monday, according to the Guardian.
The mystery of how arsenic levels in beer sold in Germany could be higher than in the water or other ingredients used to brew the beer has been solved, scientists announced here today at the 245th National Meeting & Exposition of the American Chemical Society, the world's largest scientific society.
Researchers have yet again been sent back to the drawing board in the development of the much-sought-after vaccination for smokers, which would hypothetically inhibit the action of nicotine and its pleasure-producing chemical response in the brain.
Neurologix, Inc., a biotechnology company engaged in the development of innovative therapies for the brain and central nervous system, announced that the U.S. Patent and Trademark Office (US PTO) has expanded the intellectual property protections enabled by a previously issued patent that is central to Neurologix's Parkinson's disease program. The new allowances to U.S. Patent Number 765,446, entitled "Glutamic acid decarboxylase (GAD) based delivery systems," broaden the patent's coverage beyond Parkinson's disease to include the use of GAD65 in the treatment of other neurological and related disorders.
Watson Pharmaceuticals, Inc., a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its 8mg ramelteon tablets prior to the expiration of a patent owned by Takeda Pharmaceutical Company Limited.
› Verified 6 days ago
| Entity Name | Imc-eastern Shore Family Practice Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235659319 PECOS PAC ID: 7315218450 Enrollment ID: O20170808000289 |
News Archive
"Food crises are jeopardizing efforts to achieve the Millennium Development Goal (MDG) of halving the proportion of people who suffer from hunger by 2015, United Nations (U.N.) food experts warned" on Monday, according to the Guardian.
The mystery of how arsenic levels in beer sold in Germany could be higher than in the water or other ingredients used to brew the beer has been solved, scientists announced here today at the 245th National Meeting & Exposition of the American Chemical Society, the world's largest scientific society.
Researchers have yet again been sent back to the drawing board in the development of the much-sought-after vaccination for smokers, which would hypothetically inhibit the action of nicotine and its pleasure-producing chemical response in the brain.
Neurologix, Inc., a biotechnology company engaged in the development of innovative therapies for the brain and central nervous system, announced that the U.S. Patent and Trademark Office (US PTO) has expanded the intellectual property protections enabled by a previously issued patent that is central to Neurologix's Parkinson's disease program. The new allowances to U.S. Patent Number 765,446, entitled "Glutamic acid decarboxylase (GAD) based delivery systems," broaden the patent's coverage beyond Parkinson's disease to include the use of GAD65 in the treatment of other neurological and related disorders.
Watson Pharmaceuticals, Inc., a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its 8mg ramelteon tablets prior to the expiration of a patent owned by Takeda Pharmaceutical Company Limited.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amy Elizabeth Kayl, DO 27961 Us Highway 98 Ste 14, Daphne, AL 36526-4725 Ph: (251) 626-1175 | Amy Elizabeth Kayl, DO 27961 Us Highway 98 Ste 14, Daphne, AL 36526-4725 Ph: (251) 626-1175 |
News Archive
"Food crises are jeopardizing efforts to achieve the Millennium Development Goal (MDG) of halving the proportion of people who suffer from hunger by 2015, United Nations (U.N.) food experts warned" on Monday, according to the Guardian.
The mystery of how arsenic levels in beer sold in Germany could be higher than in the water or other ingredients used to brew the beer has been solved, scientists announced here today at the 245th National Meeting & Exposition of the American Chemical Society, the world's largest scientific society.
Researchers have yet again been sent back to the drawing board in the development of the much-sought-after vaccination for smokers, which would hypothetically inhibit the action of nicotine and its pleasure-producing chemical response in the brain.
Neurologix, Inc., a biotechnology company engaged in the development of innovative therapies for the brain and central nervous system, announced that the U.S. Patent and Trademark Office (US PTO) has expanded the intellectual property protections enabled by a previously issued patent that is central to Neurologix's Parkinson's disease program. The new allowances to U.S. Patent Number 765,446, entitled "Glutamic acid decarboxylase (GAD) based delivery systems," broaden the patent's coverage beyond Parkinson's disease to include the use of GAD65 in the treatment of other neurological and related disorders.
Watson Pharmaceuticals, Inc., a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its 8mg ramelteon tablets prior to the expiration of a patent owned by Takeda Pharmaceutical Company Limited.
› Verified 6 days ago
Dr. Andrew Augustus Smith, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 27961 Highway 98, Ste 14, Daphne, AL 36526 Phone: 251-626-1175 Fax: 251-625-1507 | |
John Andrew Harcourt, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1505 Daphne Ave, Daphne, AL 36526 Phone: 251-625-2663 Fax: 251-625-3198 | |
Dr. Cynthia Sue Harbaugh, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 6631 Park Dr, Daphne, AL 36526 Phone: 251-626-5700 Fax: 251-626-5703 | |
David Andrew Johnson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 27961 Us Highway 98, Suite 14, Daphne, AL 36526 Phone: 251-626-1175 Fax: 251-591-4145 | |
Dr. Katherine M Thomas, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 6475 Van Buren Street, Covenant Hospice, Daphne, AL 36526 Phone: 251-626-5255 Fax: 251-626-5922 | |
Dr. John Gayle Van Derwood, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7101 Us Highway 90, Suite 202, Daphne, AL 36526 Phone: 251-625-8211 Fax: 251-625-8219 | |
Gordon Spafford, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 27961 Us Highway 98, Suite 20, Daphne, AL 36526 Phone: 251-621-6520 Fax: 251-621-6521 |